Literature DB >> 6776876

Mucopolysaccharidoses: ultrastructure of leukocyte inclusions.

W R Markesbery, R O Robinson, P V Falace, M D Frye.   

Abstract

Ultrastructural study of leukocytes from 7 patients with mucopolysaccharidosis (MPS) I, II, or III demonstrated a variety of membrane-bound inclusions in 34 to 68% of lymphocytes and larger mononuclear cells. The most common inclusions were membrane-bound vacuoles containing faintly osmiophilic material, but a variety of clear vacuoles, dense granular inclusions and myelin figures were also seen. Fingerprint profiles were present in small percentages in MPS II and III, indicating that they are not as specific as previously considered. Granulocytes, lymphocytes, and larger mononuclear cells from a patient with MPS VII showed many small and large membrane-bound vacuolated inclusions, some of which contained large dense granules. The presence of alterations in a readily accessible tissue such as blood indicates that ultrastructural study of leukocytes may be a useful adjunct in guiding further biochemical studies in MPS, especially in early or obscure cases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776876     DOI: 10.1002/ana.410080320

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

1.  Fingerprint profiles in lymphocytic vacuoles of mucopolysaccharidoses I-H, II, III-A, and III-B.

Authors:  H H Goebel; K Ikeda; F Schulz; U Burck; A Kohlschütter
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

2.  Ultrastructural pathology of human lymphocytes in lysosomal disorders: a contribution to their morphological diagnosis.

Authors:  K Ikeda; H H Goebel; U Burck; A Kohlschütter
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

3.  The pathology of the feline model of mucopolysaccharidosis I.

Authors:  M E Haskins; G D Aguirre; P F Jezyk; R J Desnick; D F Patterson
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.